February 10, 2026

Apellis Pharmaceuticals, Inc. (APLS) Stock Analysis: Exploring a Potential 48.70% Upside

Apellis Pharmaceuticals, Inc. (NASDAQ: APLS), a prominent player in the biotechnology sector, is captivating investor interest with its robust pipeline and promising market potential. Headquartered in..

Supernus Pharmaceuticals, Inc. (SUPN): Investor Outlook on CNS Drug Innovator with 19.56% Upside Potential

Investors looking to capitalize on the burgeoning healthcare sector might find Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) an intriguing prospect. With its focus on developing and commercializing..

Immunovant, Inc. (IMVT) Stock Analysis: Potential Upside of 47.10% Makes It a Biotech to Watch

Immunovant, Inc. (NASDAQ: IMVT), a New York-based clinical-stage biotech company, is capturing investor attention with its strategic focus on monoclonal antibodies aimed at treating autoimmune diseases...

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Unveiling a 40.86% Potential Upside in the Biotech Sector

Travere Therapeutics, Inc. (NASDAQ: TVTX) stands as a compelling player in the biotechnology industry, focusing on developing therapies for rare kidney and metabolic diseases. With its..

Evotec SE (EVO) Stock Analysis: Unveiling a 53.82% Potential Upside Amidst Current Challenges

Evotec SE (EVO), a prominent player in the healthcare sector, operates within the specialty and generic drug manufacturing industry. Headquartered in Hamburg, Germany, Evotec SE is..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a Potential 20.85% Upside in the Biotech Sector

MoonLake Immunotherapeutics (NASDAQ: MLTX), a burgeoning player in the biotechnology industry, has captured the attention of investors with its innovative approach to treating inflammatory diseases. Headquartered..

Amicus Therapeutics (FOLD) Stock Analysis: Navigating Growth in Rare Disease Biotech

Amicus Therapeutics, Inc. (NASDAQ: FOLD) is garnering attention in the biotechnology sector with its strategic focus on rare diseases, a niche that promises both potential growth..

HUTCHMED (China) Limited (HCM): Investor Outlook on a Potential 41.74% Upside

HUTCHMED (China) Limited (NASDAQ: HCM) presents a compelling opportunity for investors seeking exposure to the dynamic healthcare sector, particularly in the realm of innovative cancer treatments...

Arrowhead Pharmaceuticals (ARWR) Stock Analysis: A 30% Upside Potential in the Biotech Sector

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR), a prominent player in the biotechnology sector, has been capturing investor attention with its remarkable growth trajectory and promising pipeline of..

Mirum Pharmaceuticals, Inc. (MIRM) Stock Analysis: A Biotech Gem with 14% Upside Potential

Mirum Pharmaceuticals, Inc. (NASDAQ: MIRM) is making waves in the healthcare sector, particularly within the biotechnology industry. With a market capitalization of $6.02 billion, this U.S.-based..

Acadia Healthcare (ACHC) Stock Analysis: Evaluating a 41% Upside Potential Amidst Strong Buy Ratings

Acadia Healthcare Company, Inc. (NASDAQ: ACHC) presents itself as an intriguing opportunity for investors seeking exposure in the healthcare sector, particularly within the specialized realm of..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 106% Upside Potential Amid Healthcare Industry Dynamics

GoodRx Holdings, Inc. (NASDAQ: GDRX), a prominent player in the healthcare sector, is currently capturing investor attention with a substantial potential upside of over 106%. As..

Schrodinger, Inc. (SDGR) Stock Analysis: Unveiling an 83.82% Upside Potential

For investors with an eye on innovation within the healthcare sector, Schrodinger, Inc. (NASDAQ: SDGR) presents an intriguing opportunity. The New York-based company, with a market..

Veracyte, Inc. (VCYT) Stock Analysis: Exploring a 29.78% Upside Potential in the Diagnostics Sector

Veracyte, Inc. (NYSE: VCYT) stands out in the healthcare sector, particularly within the diagnostics and research industry. With a market capitalization of $2.9 billion, this South..

National HealthCare Corporation (NHC) Stock Analysis: A Closer Look at Strong Revenue Growth Amidst Lack of Analyst Ratings

National HealthCare Corporation (NYSE: NHC), a prominent player in the healthcare sector, operates a diversified portfolio of medical care facilities across the United States. This company,..

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring Value Amidst Challenges with a 4.67% Dividend Yield

DENTSPLY SIRONA Inc. (XRAY), a key player in the healthcare sector, particularly in medical instruments and supplies, is drawing investor attention with its robust 4.67% dividend..

Centessa Pharmaceuticals (CNTA) Stock Analysis: Exploring the 68% Potential Upside for Investors

Centessa Pharmaceuticals plc (NASDAQ: CNTA) is catching the attention of investors looking for high-growth opportunities within the healthcare sector. As a clinical-stage pharmaceutical company, Centessa is..

Brookdale Senior Living Inc. (BKD) Investor Outlook: Analyzing a 16.71% Potential Upside in the Healthcare Sector

Brookdale Senior Living Inc. (NYSE: BKD), a prominent player in the healthcare sector, specializes in managing senior living communities across the United States. With a market..

Organon & Co. (OGN) Stock Analysis: Exploring a Potential 18.3% Upside in Healthcare

Organon & Co. (NYSE: OGN), a noteworthy player in the general drug manufacturing sector, presents an intriguing opportunity for investors interested in the healthcare landscape. With..

CRISPR Therapeutics AG (CRSP) Stock Analysis: Unveiling a 69.80% Potential Upside

CRISPR Therapeutics AG (NASDAQ: CRSP) stands at the forefront of genetic innovation with its cutting-edge CRISPR/Cas9 platform, targeting a vast array of serious human diseases. As..

Search

Funds

February 10, 2026

Search

Funds

February 10, 2026

FTSE 100

Funds